Author

D. B. Poschel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. D. Merting· 2 shared C. Lu· 2 shared D. Yang· 2 shared K. Liu· 2 shared A. Barret· 1 shared D. H. Munn· 1 shared G. Zhou· 1 shared H. Shi· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. D. Merting

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PD-L1 Restrains the PD-1hiNrp1loTGFb+ Treg to block IL6+ Neutrophil tumor infiltration to Suppress Inflammation-driven Colorectal Cancer

K. Liu, D. B. Poschel, J. Klement, A. D. Merting, C. Lu, Y. Zhao, D. Yang, W. Xiao, H. Zhu, P. Rajeshwari, M. Toscano, K. Jones, K. Madwani, A. Barret, R. Bollag, , H. Shi

This study shows PD-L1 suppresses inflammation-driven colorectal cancer by regulating Tregs, neutrophils, and gut microbiota through the PD-L1/L. murinus/PD-1hiNrp1loTGFβ+ Treg/IL6+ neutrophils pathway.

bioRxiv · Oct 12, 2023 · PreprintImmunology

Tumor PD-L1 selectively suppresses type I interferon in myeloid cells to suppress CTL recruitment to promote lung metastasis

J. D. Klement, P. S. Redd, C. Lu, A. D. Merting, D. B. Poschel, D. Yang, G. Zhou, D. H. Munn, K. Liu

bioRxiv · Jun 18, 2021 · PreprintCancer Biology